Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories (“DS Labs”), a leading dermatology company focused on science-backed hair care across 50+ countries. This strategic move enhances Megalabs’ position in the global dermatology market and the US. For Megalabs, dermatology is a key focus area with a long and successful track record driven by its Medihealth line, including a wide portfolio of products, and more recently entering the minimally invasive aesthetics and fillers market with the acquisition of Croma-Pharma in Brazil and the distribution of its products in the Latam region.
Read the full article: Megalabs Acquires Majority Interest and Control of DS Laboratories //
Source: https://www.einpresswire.com/article/716203131/megalabs-acquires-majority-interest-and-control-of-ds-laboratories